The Cigna Group CI

Full chart Compare
Set alert

Price alert · CI

All alert types
302.07 USD +6.63 (+2.24%)

Nov 4, 2026, 10:46 AM EST

296.50 Day range 304.84
255.53 52-week range 316.27
YTD
+9.75%
1 year
+14.13%
Market cap
79.86B
Revenue (ttm)
282.38B
Profit margin
2.27%
EPS (ttm)
24.19
Shares out
264.24M
P/E ratio
12.49
Forward P/E
8.82
Dividend
6.24 (2.12%)
Ex-dividend date
Dec 2, 2026
YTD return
+9.75%
1-year return
+14.13%
Volume
546.24K
Avg volume
1.59M
Open
301.96
Previous close
295.44
Day's range
296.50 – 304.84
52-week range
255.53 – 316.27
Beta
0.25
Analysts
Buy
Price target
342.29 (+13.3%)
Earnings date
Nov 5, 2026

5D +1.38 (+0.46%)

295300ThuFriMonTue301.92

Key statistics

Enterprise value
102.91B
PEG ratio
0.81
Price / sales
0.28
Price / book
1.83
Dividend yield
2.11%
Payout ratio
25.38%
Revenue growth
6.70%
Free cash flow
7.98B
Total cash
7.26B
Total debt
31.88B
Return on equity
16.76%
Short % of float
2.85%
50-day average
284.26
200-day average
281.74

Financials — quick view

All financials
CI Revenue — quarterly 71.67B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CI Net income — quarterly 1.66B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CI EPS — quarterly 6.31
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

CI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 20267.52———
Jul 30, 2026Jun 30, 20267.607.78+0.18+2.37%
Apr 30, 2026Mar 31, 20267.607.79+0.19+2.50%
Feb 5, 2026Dec 31, 20257.888.08+0.20+2.54%
Oct 30, 2025Sep 30, 20257.647.83+0.19+2.49%
Jul 31, 2025Jun 30, 20257.167.20+0.04+0.56%

Upgrades / downgrades

CI analyst upgrades and downgrades
DateFirmActionFromTo
Oct 2, 2026Piper SandlermainOverweightOverweight
Oct 1, 2026RBC CapitalreitOutperformOutperform
Aug 4, 2026JefferiesdownBuyHold
Aug 3, 2026Raymond JamesdownStrong BuyOutperform
Jul 31, 2026Wells FargomainEqual-WeightEqual-Weight
Jul 31, 2026GuggenheimmainBuyBuy

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Sector
Healthcare
Industry
Healthcare Plans
Country
United States

News

Your note

Sign in to keep a note on CI — it syncs with the Stock Master app.

Insider holders

CI insider holders
InsiderRelationLatest transactionDateShares held
BRAILER DAVID JOfficerStock Award(Grant)Feb 27, 202517,815
CORDANI DAVID MChief Executive OfficerConversion of Exercise of derivative securityMay 12, 2026658,302
DENNISON ANN MChief Financial OfficerStock Award(Grant)Feb 26, 20267,745
EDER NOELLE KOfficerSaleMar 6, 202513,590
EVANKO BRIAN CChief Executive OfficerStock Award(Grant)Aug 31, 202667,563
FOSS ERIC J.DirectorStock Award(Grant)Apr 21, 202636,696

Institution ownership

CI institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.87%23,438,2506.92BJun 29, 2026
Vanguard Capital Management LLC6.54%17,276,2965.10BJun 29, 2026
State Street Corporation4.80%12,682,2593.75BJun 29, 2026
Dodge & Cox Inc.4.61%12,173,8753.60BJun 29, 2026
Massachusetts Financial Services Co.3.95%10,443,6913.08BJun 29, 2026
Sanders Capital, LLC3.82%10,098,0762.98BSep 29, 2026

Fund ownership

CI fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.18%8,398,6802.48BJun 29, 2026
Dodge & Cox Funds-Dodge & Cox Stock Fund3.02%7,985,0722.36BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.59%6,854,3552.02BJun 29, 2026
MFS SERIES TRUST I-MFS Value Fund1.59%4,199,3951.24BAug 30, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%3,520,7881.04BSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.30%3,433,8641.01BAug 30, 2026